- 专利标题: Lyophilized viral formulations
-
申请号: US14693100申请日: 2015-04-22
-
公开(公告)号: US09610352B2公开(公告)日: 2017-04-04
- 发明人: Matthew C. Coffey , Sarah Serl , Leo Pavliv
- 申请人: Oncolytics Biotech Inc.
- 申请人地址: CA Calgary, Alberta
- 专利权人: Oncolytics Biotech Inc.
- 当前专利权人: Oncolytics Biotech Inc.
- 当前专利权人地址: CA Calgary, Alberta
- 代理机构: Kilpatrick Townsend & Stockton LLP
- 主分类号: A61K47/26
- IPC分类号: A61K47/26 ; A61K9/19 ; A61K47/02 ; A61K47/18 ; A61K9/00 ; C12N7/00 ; A61K35/76 ; A61K35/00 ; A61K35/765 ; A61K35/768
摘要:
Provided herein are lyophilized viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The lyophilized viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
公开/授权文献
- US20150224198A1 LYOPHILIZED VIRAL FORMULATIONS 公开/授权日:2015-08-13
信息查询
IPC分类: